1-7 of 7
waldenstrom macroglobulinemia
Close
Sort by
Journal Articles

Toward personalized treatment in Waldenström macroglobulinemia

Jorge J. Castillo, Steven P. Treon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 365–370.
https://doi.org/10.1182/asheducation-2017.1.365
Published: 2017
Journal Articles

Treatment of patients with transformed lymphoma

Silvia Montoto
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 625–630.
https://doi.org/10.1182/asheducation-2015.1.625
Published: 2015
Journal Articles

Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis

Davide Rossi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 113–118.
https://doi.org/10.1182/asheducation-2014.1.113
Published: 2014
Journal Articles

BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma

Adrian Wiestner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 125–134.
https://doi.org/10.1182/asheducation-2014.1.125
Published: 2014
Journal Articles

Are you sure this is Waldenström macroglobulinemia?

Irene M. Ghobrial
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 586–594.
https://doi.org/10.1182/asheducation.V2012.1.586.3798562
Published: 2012
Journal Articles

Dealing with Neuropathy in Plasma-Cell Dyscrasias

Pieter Sonneveld, Joost L.M. Jongen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 423–430.
https://doi.org/10.1182/asheducation-2010.1.423
Published: 2010
Journal Articles

Amyloidosis and Waldenström’s Macroglobulinemia

Morie A. Gertz, Giampaolo Merlini, Steven P. Treon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 257–282.
https://doi.org/10.1182/asheducation-2004.1.257
Published: 2004